X
1. Chloroacetaldehyde Dimethyl Acetal
2. 97-97-2
3. Dimethylchloroacetal
4. Dimethyl Chloroacetal
5. Ethane, 2-chloro-1,1-dimethoxy-
6. Dimethyl Chloracetal
7. 2-chloro-1,1-dimethoxy-ethane
8. Chloroacetaldehyde Dimethylacetal
9. Chloroacetaldehyde, Dimethyl Acetal
10. 2-chloroacetaldehyde, Dimethyl Acetal
11. Methyl Chloroacetal
12. Acetaldehyde, Chloro-, Dimethyl Acetal
13. 1-chloro-2,2-dimethoxyethane
14. 1kpa4h9t18
15. 2-chloroacetaldehyde Dimethyl Acetal
16. Nsc-60388
17. Mfcd00000948
18. Unii-1kpa4h9t18
19. Chloroacetaldehydedimethylacetal
20. Einecs 202-624-0
21. Chlorodimethyl Acetal
22. Nsc 60388
23. Ec 202-624-0
24. Ghl.pd_mitscher_leg0.695
25. Schembl252600
26. 1,1-dimethoxy-2-chloroethane
27. Chloracetaldehyde Dimethylacetal
28. Chloroacetaldehyde-dimethylacetal
29. Dtxsid1059157
30. Crzjpeibpqwdgj-uhfffaoysa-
31. Amy3314
32. 2-chloranyl-1,1-dimethoxy-ethane
33. Chloro Acetaldehyde Dimethyl Acetal
34. 2,2-dimethoxyethyl Chloride
35. Bcp21838
36. Nsc60388
37. Zinc1690179
38. Bbl011494
39. Stl146606
40. Akos000121592
41. Chloroacetaldehyde Dimethyl Acetal, 98%
42. Da-19351
43. 2-chloro-1,1-dimethoxyethane;dimethylchloroacetal
44. A845778
45. W-100099
46. Q27252548
47. F0001-2309
48. Chloroacetaldehyde Dimethyl Acetal, Produced By Wacker Chemie Ag, Burghausen, Germany, >=99.0% (gc)
| Molecular Weight | 124.56 g/mol |
|---|---|
| Molecular Formula | C4H9ClO2 |
| XLogP3 | 0.7 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 3 |
| Exact Mass | 124.0291072 g/mol |
| Monoisotopic Mass | 124.0291072 g/mol |
| Topological Polar Surface Area | 18.5 Ų |
| Heavy Atom Count | 7 |
| Formal Charge | 0 |
| Complexity | 36.7 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
List of Suppliers
Vietnam Medi Pharm 2024
Not Confirmed
Contact SupplierNote: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Vietnam Medi Pharm 2024
Not Confirmed
Contact SupplierVietnam Medi Pharm 2024
Not Confirmed
Contact Supplier
Market Place
PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.
